ProtonsRadiotherapyRadiotherapy DosageRadiotherapy, ConformalRadiotherapy, AdjuvantParticle SizeProton PumpsRadiotherapy, Intensity-ModulatedRadiotherapy Planning, Computer-AssistedRadiotherapy, High-EnergyCombined Modality TherapyDose FractionationRadiation InjuriesRadiotherapy, Computer-AssistedRadiotherapy, Image-GuidedProton Pump InhibitorsRadiation OncologyTreatment OutcomeDose-Response Relationship, RadiationRadiosurgeryHead and Neck NeoplasmsBrachytherapyNeoplasm Recurrence, LocalNeoplasm StagingMagnetic Resonance SpectroscopyChemoradiotherapyHydrogen-Ion ConcentrationBrain NeoplasmsOrgans at RiskAntineoplastic Combined Chemotherapy ProtocolsNasopharyngeal NeoplasmsCarcinoma, Squamous CellDisease-Free SurvivalRadiation ToleranceRadiometryRetrospective StudiesSurvival RateVirionParticle AcceleratorsLung NeoplasmsSurvival AnalysisRadiation-Sensitizing AgentsFollow-Up StudiesRadiation DosageRectal NeoplasmsTime FactorsChemotherapy, AdjuvantCranial IrradiationCisplatinPrognosisHeavy Ion RadiotherapyProstatic NeoplasmsRadiation PneumonitisProton-Motive ForceNeoplasms, Radiation-InducedBreast NeoplasmsPelvic NeoplasmsLaryngeal NeoplasmsMicroscopy, ElectronMastectomy, SegmentalTomography, X-Ray ComputedHodgkin DiseaseRadiodermatitisVincristineOrgan Sparing TreatmentsNeoplasmsNeoplasms, Second PrimaryDacarbazineKineticsSignal Recognition ParticleAntineoplastic AgentsXerostomiaProcarbazineFluorouracilNeoadjuvant TherapyHeavy IonsRadioisotope TeletherapySpinal NeoplasmsNanoparticlesCobalt RadioisotopesAdenocarcinomaWaterCarcinoma, Non-Small-Cell LungPalliative CareSubmitochondrial ParticlesVirus AssemblyMagnetic Resonance ImagingGlioblastomaUterine Cervical NeoplasmsLymphatic IrradiationModels, MolecularMolecular Sequence DataCarcinomaMechlorethamineProton-Translocating ATPasesBacteriorhodopsinsRadiation-Protective AgentsAerosolsGliomaAlpha Particles